Rubric Capital Management LP
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1687509
NEW YORK, NY
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$194,878,354
-$45,328,242 QoQ
Shares Held
8,271,577
0.0% QoQ
Ownership
6.61%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. ARQT ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,712,373 | $44,288,609 |
All Filings in ARQT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,878,354 | 8,271,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $240,206,596 | 8,271,577 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $202,627,264 | 10,749,457 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $150,707,387 | 10,749,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $171,518,750 | 10,966,672 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $152,765,740 | 10,966,672 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $101,990,049 | 10,966,672 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $91,295,049 | 9,816,672 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $74,424,100 | 7,510,000 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $21,461,831 | 6,644,530 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,733,354 | 5,034,530 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $46,549,570 | 4,884,530 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $38,500,000 | 3,500,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,589,281 | 2,742,519 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $9,020,818 | 472,047 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,823,433 | 226,346 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||